1246934-51-9Relevant academic research and scientific papers
Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2- chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist
Lee, Jinhwa,Seo, Hee Jeong,Lee, Suk Ho,Kim, Jeongmin,Jung, Myung Eun,Lee, Sung-Han,Song, Kwang-Seop,Lee, Junwon,Kang, Suk Youn,Kim, Min Ju,Kim, Mi-Soon,Son, Eun-Jung,Lee, Minwoo,Han, Ho-Kyun
, p. 6377 - 6388 (2010)
Structure-activity relationship studies in a series of diarylpyrazolyl thiadiazoles identified cannabinoid-1 receptor antagonists with excellent potency and selectivity. Based on its exceptional in vivo efficacy in animal models and its favorable pharmaco
